James M Murithi
4PUBLICATIONS
76CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 19, 2022
The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple <i>Plasmodium</i> kinases and life cycle stages.Lauren B Arendse, James M Murithi, Tarrick Qahash
|Jul 22, 2021
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to <i>Plasmodium falciparum</i> parasite resistance.James M Murithi, Cécile Pascal, Jade Bath
|Jun 07, 2019
Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents.Barbara H Stokes, Euna Yoo, James M Murithi
|Jan 13, 2018
Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics.Annie N Cowell, Eva S Istvan, Amanda K Lukens
Pageof 1
Frequent Collaborators
4 joint publications
David A Fidock
2 joint publications
Madeline R Luth
2 joint publications
Charisse Flerida A Pasaje
2 joint publications
Elizabeth A Winzeler
2 joint publications
Jacquin C Niles
2 joint publications
Nina F Gnädig
2 joint publications
Manuel Llinás
1 joint publications
Eva S Istvan
1 joint publications
Kelly Chibale
1 joint publications
Manu Vanaerschot
